AGP collaborates with Childlife Foundation on Children’s Day 2023

AGP Launched Peridots – A Thanda Solution to Acidity, Gas and Indigestion

AGP secures 2nd Position at BCR Awards 2022

Hajj 2023


AGP wins Top Exporter Award at 6th PPMA Summit

AGP sponsors KDSP Carnival 2023

AGP bags big win at GDEIB Awards 2023

AGP continues partnership with IBA

AGP continues collaboration with TCF

AGP joins hands with SKMF

AGP continues partnership with ACF

AGP conducts Allergy Awareness Session At Pak Turk Maarif

Gong-Ringing Ceremony of AGP at PSX

Home > Products > Doxium

Product List




Calcium Dobesilate


Therapeutic Class:

Systemic Vasoprotectives



Each Doxium capsule contains
calcium dobesilate monohydrate 500 mg.



Calcium dobesilate acts on the
capillary walls by regulating its impaired physiological
functions-increased permeability and decreased resistance. It increases
erythrocyte flexibility, inhibits platelet hyperaggregation and in diabetic
retinopathy, it reduces plasma and blood hyperviscosity, thus improving
blood rheological properties and tissue irrigation. These effects allow to
correct capillary dysfunctions either of functional origin or caused by
constitutional or acquired metabolic disorders. Calcium dobesilate contributes
to reduce edema.



  • Microangiopathies, in particular Diabetic Retinopathy.
  • Clinical signs of Chronic Venous Insufficiency in the lower limbs (pain, cramps, paresthesia, oedema, stasis dermatosis).
  • As adjuvant in Superficial Thrombophlebitis.
  • Haemorrhoidal Syndrome


Generally 500 to 1000 mg – 1
capsule once or twice a day to be taken with the main meals. Treatment
duration, which is generally between a few weeks and several months,
depends on the disease and its evolution. Dosage should be adapted
individually according to the severity of the case.



500 mg caps 30’s